Vaxil Bio Ltd (VXL) - Total Liabilities

Latest as of September 2025: CA$8.00K CAD ≈ $5.79K USD

Based on the latest financial reports, Vaxil Bio Ltd (VXL) has total liabilities worth CA$8.00K CAD (≈ $5.79K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Vaxil Bio Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Vaxil Bio Ltd - Total Liabilities Trend (2009–2024)

This chart illustrates how Vaxil Bio Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see VXL total asset value.

Vaxil Bio Ltd Competitors by Total Liabilities

The table below lists competitors of Vaxil Bio Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Tongaat JSE:TON	South Africa	ZAC7.30 Billion
Hemogenyx Pharmaceuticals PLC LSE:HEMO	UK	GBX3.65 Million
Multistack International Ltd AU:MSI	Australia	AU$2.90 Million
Europa Oil & Gas Holdings LSE:EOG	UK	GBX6.00 Million
Elixxer Ltd V:ELXR	Canada	CA$17.22 Million
Altair Resources Inc V:AVX	Canada	CA$3.11 Million
Annum Bhd KLSE:5082	Malaysia	RM20.48 Million
Hawkeye Gold and Diamond Inc V:HAWK	Canada	CA$1.70 Million

Liability Composition Analysis (2009–2024)

This chart breaks down Vaxil Bio Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Vaxil Bio Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	75.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.01	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.01	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vaxil Bio Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vaxil Bio Ltd (2009–2024)

The table below shows the annual total liabilities of Vaxil Bio Ltd from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$17.00K ≈ $12.30K	-80.00%
2023-12-31	CA$85.00K ≈ $61.49K	-79.01%
2022-12-31	CA$405.00K ≈ $292.97K	-30.77%
2021-12-31	CA$585.00K ≈ $423.18K	-31.74%
2020-12-31	CA$857.00K ≈ $619.94K	+8.76%
2019-12-31	CA$788.00K ≈ $570.03K	+73.19%
2018-12-31	CA$455.00K ≈ $329.14K	-42.91%
2017-12-31	CA$797.00K ≈ $576.54K	+42.07%
2016-12-31	CA$561.00K ≈ $405.82K	+10.65%
2015-12-31	CA$507.00K ≈ $366.76K	+523.25%
2014-12-31	CA$81.35K ≈ $58.85K	+25.17%
2013-12-31	CA$64.99K ≈ $47.01K	-67.34%
2012-12-31	CA$199.02K ≈ $143.97K	+100.68%
2011-12-31	CA$99.17K ≈ $71.74K	+159.81%
2010-12-31	CA$38.17K ≈ $27.61K	+31.48%
2009-12-31	CA$29.03K ≈ $21.00K	--

About Vaxil Bio Ltd

V:VXL Canada Biotechnology

Market Cap

$287.36K

CA$397.24K CAD

Market Cap Rank

#31243 Global

#1667 in Canada

Share Price

CA$0.15

Change (1 day)

-3.33%

52-Week Range

CA$0.13 - CA$0.29

All Time High

CA$0.70